StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance NASDAQ:TTNP opened at $7.10 on Monday. The firm’s 50-day moving average price is $7.34 and its 200-day moving average […]